SCHEMBL164424

SCHEMBL164424

Cc1ccc(C(=O)NCc2ccccn2)c(C)c1C(N)=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.57
RAB9A P51151 3/20 0.57
L3MBTL1 Q9Y468 2/20 0.56
ALDH1A1 P00352 4/20 0.54
KDM4E B2RXH2 3/20 0.54
LMNA P02545 2/20 0.52
HTT P42858 2/20 0.52
CYP1A2 P05177 1/20 0.52
POLB P06746 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.50
NPC1 O15118 2/20 0.50
MAPT P10636 1/20 0.50
TDP1 Q9NUW8 1/20 0.49
HSD17B10 Q99714 2/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
ADORA2A P29274 1/20 0.48
ADORA1 P30542 1/20 0.48
GLA P06280 1/20 0.48
GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL164426 0.90 L3MBTL1 (0.55) HPGDRAB9AL3MBTL1ALDH1A1KDM4E
SCHEMBL6651573 0.88 SMN1; SMN2 (0.49) RAB9AALDH1A1KDM4EPOLBSMN1; SMN2
SCHEMBL166870 0.84 ALDH1A1 (0.56) HPGDRAB9AL3MBTL1ALDH1A1KDM4E
SCHEMBL13534520 0.81 HPGD (0.63) HPGDRAB9AL3MBTL1ALDH1A1KDM4E
SCHEMBL27680048 0.81 HPGD (0.64) HPGDRAB9AL3MBTL1ALDH1A1KDM4E
SCHEMBL5321616 0.79 HPGD (0.69) HPGDRAB9AL3MBTL1ALDH1A1KDM4E
SCHEMBL27737857 0.78 HPGD (0.62) HPGDRAB9AL3MBTL1ALDH1A1KDM4E
SCHEMBL29451525 0.78 NPC1 (0.60) HPGDRAB9AL3MBTL1ALDH1A1KDM4E
SCHEMBL740129 0.75 HPGD (0.66) HPGDRAB9AL3MBTL1ALDH1A1KDM4E
SCHEMBL166266 0.75 RAB9A (0.54) RAB9AHTTPOLBSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611441-A1 BACE INHIBITORS FOR USE IN THE TREATMENT OF DIABETES F.HOFFMANN-LA ROCHE AG (CH) 2013-07-10 EP disclosed
WO-2012028563-A1 BACE INHIBITORS FOR USE IN THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2012-03-08 WO disclosed